Company Search:
Advanced Search
Sponsored Links
Thrombogenics Nv Company Snapshot
Thrombogenics Nv operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Thrombogenics Nv with three other miscellaneous service companies in Europe: Bioinvent International AB of Sweden (2016 sales of 71.28 million Swedish Kronor [US$8.90 million] of which 100% was Drug Development), Genfit of France (6.78 million Euro [US$8.31 million] of which 100% was Therapeutic Drugs), and Saniona AB which is based in Sweden (74.92 million Swedish Kronor [US$9.35 million] ).

Sales Analysis. During the year ended December of 2016, sales at Thrombogenics Nv were 7.10 million Euro (US$8.71 million). This is a sharp decrease of 36.6% versus 2015, when the company's sales were 11.20 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Thrombogenics Nv
  Stock Performance Chart for Thrombogenics Nv
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 3.96
(Figures in Euro)
1 Week 3.7%   13 Weeks 15.0%  
4 Weeks -7.9%   52 Weeks 32.8%  
Thrombogenics Nv Key Data:
  Ticker: THR Country: Belgium
  Exchanges: BRU Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 7,104,000
(Year Ending Jan 2017).
Employees: 80
  Currency: Euro Market Cap: 142,933,622
  Fiscal Yr Ends: December Shares Outstanding: 36,094,349
  Share Type: ACTIONS ORDINAIRES Closely Held Shares: 5,686,274
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.